Company Filing History:
5 out of 42 
1 out of 1 Years Active: 2012-2019
Title: The Innovations of Stefan Engelhardt
Introduction
Stefan Engelhardt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the area of fibrosis and related diseases. With a total of 6 patents to his name, Engelhardt's work has the potential to impact diagnostic and therapeutic approaches in medicine.
Latest Patents
Engelhardt's latest patents focus on MicroRNA (miRNA) and its downstream targets for diagnostic and therapeutic purposes. One of his inventions is directed towards a method for diagnosing fibrosis and/or fibrosis-related diseases. Additionally, he has developed a method for screening pharmaceutically active compounds for the treatment of these conditions. His inventions also include compositions aimed at the treatment, amelioration, and prevention of fibrosis. Notably, some of these compositions modulate the activity of miRNA, specifically inhibiting the activity of miR-21 to address fibrosis-related issues.
Career Highlights
Throughout his career, Engelhardt has been associated with prestigious institutions such as Julius-Maximilians-Universität Würzburg. His work at these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Engelhardt has collaborated with esteemed colleagues, including Thomas Thum and Johann Bauersachs. These partnerships have further enriched his research and innovation efforts.
Conclusion
Stefan Engelhardt's contributions to the field of medical research, particularly in the area of fibrosis, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing diagnostic and therapeutic methods in medicine.